Medical conditions and modifiable risk factors for myelodysplastic syndrome: a systematic review.

Authors
Category Systematic review
JournalCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Year 2019
BACKGROUND: The aim of this systematic review was to evaluate medical conditions and modifiable risk factors for myelodysplastic syndromes (MDS) using the 2001 or 2008 World Health Organization (WHO) diagnostic criteria. METHODS: PubMed, MEDLINE, and Scopus databases were searched for studies published between January 2001-August 2017. Study characteristics and findings were abstracted for each article. RESULTS: Thirteen articles (4 cohort, 9 case-control) met the inclusion criteria. Smoking and alcohol use were each evaluated as potential MDS risk factors in four studies. Body mass index and anemia were each evaluated in two studies. Other potential risk factors evaluated in single studies included physical activity, dietary intake (tea, isoflavones, meat, fruit or vegetables), history of allergies, autoimmune disorders and community-acquired infections, and use of anti-tuberculosis drugs, traditional Chinese medicines or hair dyes. CONCLUSIONS: Higher BMI, smoking, a history of autoimmune disorders, community acquired infections, history of anemia, and use of anti-tuberculosis drugs were associated with higher risk of MDS. Vigorous physical activity, and tea and dietary isoflavone intake were associated with lower MDS risk. Findings suggest no association between the other factors and risk of MDS. IMPACT: Research on risk factors for MDS is limited, and further research in larger studies is needed.
Epistemonikos ID: 673b7982a43b73fef1387ecde1ded525288d83f5
First added on: Jun 20, 2019